Evaluation of pericardial effusion

References

Key articles

Savage DD, Garrison RJ, Brand F, et al. Prevalence and correlates of posterior extra echocardiographic spaces in a free-living population based sample (the Framingham study). Am J Cardio. 1983;51:1207-1212. Abstract

Adler Y, Charron P, Imazio M, et al. 2015 ESC guidelines on the diagnosis and management of pericardial diseases. Eur Heart J. 2015;36:2921-2964.Full text  Abstract

Imazio M, Colopi M, De Ferrari GM. Pericardial diseases in patients with cancer: contemporary prevalence, management and outcomes. Heart. 2020 Apr;106(8):569-74. Abstract

Sagrista-Sauleda J, Merce J, Permanyer-Miralda G, et al. Clinical clues to the causes of large pericardial effusions. Am J Med. 2000 Aug 1;109(2):95-101. Abstract

Reference articles

1. Savage DD, Garrison RJ, Brand F, et al. Prevalence and correlates of posterior extra echocardiographic spaces in a free-living population based sample (the Framingham study). Am J Cardio. 1983;51:1207-1212. Abstract

2. Imazio M, Mayosi BM, Brucato A, et al. Triage and management of pericardial effusion. J Cardiovasc Med (Hagerstown). 2010 Dec;11(12):928-35. Abstract

3. Arntfield RT, Millington SJ. Point of care cardiac ultrasound applications in the emergency department and intensive care unit - a review. Curr Cardiol Rev. 2012 May;8(2):98-108.Full text  Abstract

4. Hoit BD. Pericardial effusion and cardiac tamponade in the new millennium. Curr Cardiol Rep. 2017 Jul;19(7):57. Abstract

5. Adler Y, Charron P, Imazio M, et al. 2015 ESC guidelines on the diagnosis and management of pericardial diseases. Eur Heart J. 2015;36:2921-2964.Full text  Abstract

6. Klein AL, Abbara S, Agler DA, et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 2013 Sep;26(9):965-1012.e15.Full text  Abstract

7. Strobbe A, Adriaenssens T, Bennett J, et al. Etiology and long-term outcome of patients undergoing pericardiocentesis. J Am Heart Assoc. 2017 Dec 23;6(12):e007598.Full text  Abstract

8. Agarwal V, El Hayek G, Chavez P, et al. A structured, parsimonious approach to establish the cause of moderate-to-large pericardial effusion. Am J Cardiol. 2014 Aug 1;114(3):479-82. Abstract

9. Sánchez-Enrique C, Nuñez-Gil IJ, Viana-Tejedor A, et al. Cause and long-term outcome of cardiac tamponade. Am J Cardiol. 2016 Feb 15;117(4):664-9. Abstract

10. Ntsekhe M, Mayosi BM. Tuberculous pericarditis with and without HIV. Heart Fail Rev. 2013 May;18(3):367-73.Full text  Abstract

11. Burazor I, Imazio M, Markel G, et al. Malignant pericardial effusion. Cardiology. 2013;124(4):224-32. Abstract

12. Imazio M, Colopi M, De Ferrari GM. Pericardial diseases in patients with cancer: contemporary prevalence, management and outcomes. Heart. 2020 Apr;106(8):569-74. Abstract

13. Chang HM, Okwuosa TM, Scarabelli T, et al. Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: Part 2. J Am Coll Cardiol. 2017 Nov 14;70(20):2552-65.Full text  Abstract

14. Saade A, Mansuet-Lupo A, Arrondeau J, et al. Pericardial effusion under nivolumab: case-reports and review of the literature. J Immunother Cancer. 2019 Oct 18;7(1):266.Full text  Abstract

15. Imazio M, Adler Y. Management of pericardial effusion. Eur Heart J. 2013 Apr;34(16):1186-97.Full text  Abstract

16. Pankuweit S, Stein A, Karatolios K, et al. Viral genomes in the pericardial fluid and in peri- and epicardial biopsies from a German cohort of patients with large to moderate pericardial effusions. Heart Fail Rev. 2013 May;18(3):329-36. Abstract

17. Patel H, Patel C, Soni M, et al. Acute primary pneumococcal purulent pericarditis with cardiac tamponade: a case report and literature review. Medicine (Baltimore). 2015 Oct;94(41):e1709.Full text  Abstract

18. Sotoudeh Anvari M, Kianinejad R, Boroumand MA, et al. Bacterial pericarditis and antimicrobial resistance at the Tehran Heart Center, Iran. J Infect Dev Ctries. 2015 Jul 30;9(7):780-4.Full text  Abstract

19. Noubiap JJ, Agbor VN, Ndoadoumgue AL, et al. Epidemiology of pericardial diseases in Africa: a systematic scoping review. Heart. 2019 Feb;105(3):180-8. Abstract

20. Porcel JM, Esquerda A, Bielsa S. Diagnostic performance of adenosine deaminase activity in pleural fluid: a single-center experience with over 2100 consecutive patients. Eur J Intern Med. 2010 Oct;21(5):419-23. Abstract

21. Koh KK, Kim EJ, Cho CH, et al. Adenosine deaminase and carcinoembryonic antigen in pericardial effusion diagnosis, especially in suspected tuberculous pericarditis. Circulation. 1994 Jun;89(6):2728-35.Full text  Abstract

22. Liu J, Mouhayar E, Tarrand JJ, et al. Fulminant Cryptococcus neoformans infection with fatal pericardial tamponade in a patient with chronic myelomonocytic leukaemia who was treated with ruxolitinib: case report and review of fungal pericarditis. Mycoses. 2018 Apr;61(4):245-55. Abstract

23. Biso S, Lekkham R, Climaco A. Aspergillus pericarditis with tamponade in a renal transplant patient. Case Rep Cardiol. 2017;2017:7134586.Full text  Abstract

24. Rabinovici R, Szewczyk D, Ovadia P, et al. Candida pericarditis: clinical profile and treatment. Ann Thorac Surg. 1997 Apr;63(4):1200-4.Full text  Abstract

25. Acquatella H. Echocardiography in Chagas heart disease. Circulation. 2007;115:1124-1131.Full text  Abstract

26. Pepi M, Muratori M, Barbier P, et al. Pericardial effusion after cardiac surgery: incidence, site, size, and haemodynamic consequences. Br Heart J. 1997;72:327-331.Full text  Abstract

27. Ikäheimo MJ, Huikuri HV, Airaksinen KE, et al. Pericardial effusion after cardiac surgery: incidence, relation to the type of surgery, antithrombotic therapy, and early coronary bypass graft patency. Am Heart J. 1988 Jul;116(1 pt 1):97-102. Abstract

28. Khan NK, Järvelä KM, Loisa EL, et al. Incidence, presentation and risk factors of late postoperative pericardial effusions requiring invasive treatment after cardiac surgery. Interact Cardiovasc Thorac Surg. 2017 Jun 1;24(6):835-40.Full text  Abstract

29. Jaussaud N, Boignard A, Durand M, et al. Percutaneous drainage of postoperative pericardial effusion in cardiac surgery. J Interv Cardiol. 2012 Feb;25(1):95-101.Full text  Abstract

30. Gaudino M, Anselmi A, Pavone N, et al. Constrictive pericarditis after cardiac surgery. Ann Thorac Surg. 2013 Feb;95(2):731-6.Full text  Abstract

31. Natanzon A, Kronzon I. Pericardial and pleural effusions in congestive heart failure-anatomical, pathophysiologic, and clinical considerations. Am J Med Sci. 2009 Sep;338(3):211-6. Abstract

32. Sagristà-Sauleda J, Angel J, Permanyer-Miralda G, et al. Long-term follow-up of idiopathic chronic pericardial effusion. N Engl J Med. 1999 Dec 30;341(27):2054-9.Full text  Abstract

33. Kataoka H. Pericardial and pleural effusions in decompensated chronic heart failure. Am Heart J. 2000;139:918-923. Abstract

34. Batal O, Dardari Z, Costabile C, et al. Prognostic value of pericardial effusion on serial echocardiograms in pulmonary arterial hypertension. Echocardiography. 2015 Oct;32(10):1471-6. Abstract

35. Hiratzka LF, Bakris GL, Beckman JA, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease. J Am Coll Cardiol. 2010 Apr 6;55(14):e27-129.Full text  Abstract

36. Gilon D, Mehta RH, Oh JK, et al. Characteristics and in-hospital outcomes of patients with cardiac tamponade complicating type A acute aortic dissection. Am J Cardiol. 2009 Apr 1;103(7):1029-31. Abstract

37. Imazio M, Brucato A, Rovere ME, et al. Contemporary features, risk factors, and prognosis of the post-pericardiotomy syndrome. Am J Cardiol. 2011 Oct 15;108(8):1183-7. Abstract

38. Albani S, Fabris E, Stolfo D, et al. Prognostic relevance of pericardial effusion in STEMI patients treated by primary percutaneous coronary intervention: a 10-year single-centre experience. Eur Heart J Acute Cardiovasc Care. 2019 Nov 7 [Epub ahead of print]. Abstract

39. Bière L, Mateus V, Clerfond G, et al. Predictive factors of pericardial effusion after a first acute myocardial infarction and successful reperfusion. Am J Cardiol. 2015 Aug 15;116(4):497-503. Abstract

40. Harris DG, Janson JT, Van Wyk J, et al. Delayed pericardial effusion following stab wounds to the chest. Eur J Cardiothorac Surg. 2003;23:473-476. Abstract

41. Bataille S, Brunet P, Decourt A, et al. Pericarditis in uremic patients: serum albumin and size of pericardial effusion predict drainage necessity. J Nephrol. 2015 Feb;28(1):97-104. Abstract

42. Cuomo JR, Sharma GK, Conger PD, et al. Novel concepts in radiation-induced cardiovascular disease. World J Cardiol. 2016 Sep 26;8(9):504-19.Full text  Abstract

43. Szpakowski N, Desai MY. Radiation-associated pericardial disease. Curr Cardiol Rep. 2019 Jul 27;21(9):97. Abstract

44. Ning MS, Tang L, Gomez DR, et al. Incidence and predictors of pericardial effusion after chemoradiation therapy for locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):70-9. Abstract

45. Mohty D, Damy T, Cosnay P, et al. Cardiac amyloidosis: updates in diagnosis and management. Arch Cardiovasc Dis. 2013 Oct;106(10):528-40.Full text  Abstract

46. Imazio M. Pericardial involvement in systemic inflammatory diseases. Heart. 2011 Nov;97(22):1882-92. Abstract

47. Chahine J, Ala CK, Gentry JL, et al. Pericardial diseases in patients with hypothyroidism. Heart. 2019 Jul;105(13):1027-33. Abstract

48. Delvigne A, Demoulin A, Smitz J, et al. The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. I. Clinical and biological features. Hum Reprod. 1993 Sep;8(9):1353-60. Abstract

49. Le Saché F, Dibie A, Lamer C. Cardiac tamponade after ovarian stimulation. N Engl J Med. 2007 Jan 25;356(4):425-6. Abstract

50. Vasoo S. Drug-induced lupus: an update. Lupus. 2006;15:757-761. Abstract

51. Ristić AD, Imazio M, Adler Y, et al. Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2014 Sep 7;35(34):2279-84.Full text  Abstract

52. LeWinter MM. Clinical practice. Acute pericarditis. N Engl J Med. 2014 Dec 18;371(25):2410-6. Abstract

53. Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019 Sep;78(9):1151-9.Full text  Abstract

54. Weitzman LB, Tinker WP, Kronzon I, et al. The incidence and natural history of pericardial effusion after cardiac surgery - an echocardiographic study. Circulation. 1984;69:506-511. Abstract

55. Roy CL, Minor MA, Brookhart MA, et al. Does this patient with a pericardial effusion have cardiac tamponade? JAMA. 2007 Apr 25;297(16):1810-8. Abstract

56. Xanthopoulos A, Skoularigis J. Diagnosis of acute pericarditis. E-J Cardiol Pract. 2017;15:15.Full text

57. Kligerman S. Imaging of pericardial disease. Radiol Clin North Am. 2019 Jan;57(1):179-99. Abstract

58. Chetrit M, Xu B, Kwon DH, et al. Imaging-guided therapies for pericardial diseases. JACC Cardiovasc Imaging. 2020 Jun;13(6):1422-7. Abstract

59. Sagrista-Sauleda J, Merce J, Permanyer-Miralda G, et al. Clinical clues to the causes of large pericardial effusions. Am J Med. 2000 Aug 1;109(2):95-101. Abstract

60. Permanyer-Miralda G, Sagrista-Sauleda J, Soler-Soler J. Primary acute pericardial disease: a prospective series of 231 consecutive patients. Am J Cardiol. 1985;56:623-630. Abstract

61. Argulian E, Makani H, Herzog E. Pericardial effusion and tamponade. In: Herzog E (ed). Management of pericardial disease. Switzerland: Springer International Publishing; 2014:129-37.

62. Ben-Horin S, Bank I, Shinfeld A, et al. Diagnostic value of the biochemical composition of pericardial effusions in patients undergoing pericardiocentesis. Am J Cardiol. 2007;99:1294-1297. Abstract

63. Seferović PM, Ristić AD, Maksimović R, et al. Diagnostic value of pericardial biopsy: improvement with extensive sampling enabled by pericardioscopy. Circulation. 2003;107:978-983.Full text  Abstract

64. Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation. 2005;112:3608-3616.Full text  Abstract

65. Mayosi BM, Wiysonge CS, Ntsekhe M, et al. Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registry. BMC Infect Dis. 2006;6:2.Full text  Abstract

66. Dorbala S, Ando Y, Bokhari S, et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-Evidence base and standardized methods of imaging. Circ Cardiovasc Imaging. 2021 Jul;14(7):e000029.Full text  Abstract

67. Garcia-Pavia P, Rapezzi C, Adler Y, et al. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2021 Apr 21;42(16):1554-68.Full text  Abstract

68. Gillmore JD, Maurer MS, Falk RH, et al. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation. 2016 Jun 14;133(24):2404-12.Full text  Abstract

Use of this content is subject to our disclaimer